Received Oct 7, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MNQ | MENINGOCOCCAL CONJUGATE (MENVEO) | NOVARTIS VACCINES AND DIAGNOSTICS | UNK | X4T99 | — |
received a vaccine with the expiration date of 30 Sep 2025; This non-serious case was reported by a other health professional via call center representative and described the occurrence of expired vaccine used in a adolescent male patient who received Men ACWY-CRM NVS (Menveo) (batch number X4T99, expiry date 30-SEP-2025) for prophylaxis. On 01-OCT-2025, the patient received Menveo. On 01-OCT-2025, an unknown time after receiving Menveo, the patient experienced expired vaccine used (Verbatim: received a vaccine with the expiration date of 30 Sep 2025). The outcome of the expired vaccine used was not applicable. Additional Information: GSK Receipt Date: 02-OCT-2025 The medical assistant reported she administered an expired dose of Menveo to a patient. The patient received Menveo 1 vial on 1-Oct-2025 that expired on 30-Sep-2025. The vaccine administration facility is the same as primary reporter.